[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371781-105":59,"doc-detail-371781-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","constructing-a-pancancer-ubiquitination-regulatory-network-to-determine-tumor-characteristics-immunotherapy-response-and-prognosis","Constructing a pancancer ubiquitination regulatory network to determine tumor characteristics, immunotherapy response, and prognosis","","Background Ubiquitination is a key reversible posttranslational modification, yet its pancancer role as a regulatory hub for prognosis and immunotherapy response remains insufficiently defined. Methods integrated 4,709 patients from 26 cohorts across five solid tumors, mapped molecular profiles to interaction networks, and used Cox regression and Kaplan-Meier survival analyses. Functional enrichment and protein–protein interaction work prioritized key pathways and genes, then validated findings in independent cohorts and experimental models. Results identified a conserved ubiquitination-related prognostic signature stratifying risk and linking to immunotherapy response, macrophage infiltration, and OTUB1–TRIM28 control of the MYC pathway. Conclusion A pancancer ubiquitination network and prognostic model clarifies mechanisms and supports prediction of outcomes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/constructing-a-pancancer-ubiquitination-regulatory-network-to-determine-tumor-characteristics-immunotherapy-response-and-prognosis/371781/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/constructing-a-pancancer-ubiquitination-regulatory-network-to-determine-tumor-characteristics-immunotherapy-response-and-prognosis/371781.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of constructing the pancancer ubiquitination regulatory network?","Question",{"text":112,"@type":113},"To build a pancancer ubiquitination regulatory network and prognostic model that reveals important pathways and helps predict patient prognosis and biological mechanisms, including immunotherapy response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were prognostic effects evaluated in this study?",{"text":117,"@type":113},"The study used Cox regression and Kaplan-Meier survival methods, integrating patient molecular profiles mapped to the interaction network.",{"name":119,"@type":110,"acceptedAnswer":120},"What is URPS and how does it impact patient risk stratification?",{"text":121,"@type":113},"URPS is a conserved ubiquitination-related prognostic signature that stratifies patients into high-risk and low-risk groups with distinct survival outcomes across analyzed cancers.",{"name":123,"@type":110,"acceptedAnswer":124},"Which biological mechanism does the study highlight as crucial for prognosis?",{"text":125,"@type":113},"It highlights OTUB1-TRIM28 ubiquitination as a key regulator that modulates the MYC pathway, influences the tumor microenvironment, and affects patient prognosis.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},371781,1791473969,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Open access Original research  \n Constructing a pancancer ubiquitination  \nregulatory network to determine tumor characteristics, immunotherapy response, and prognosis  \nZheng Zhou,1 Bing-Zhi Wang,2 Chaoqi Zhang,1 Guochao Zhang,1 Peng Wu,1 Xin Dong,3 Nan Sun,1 Jie He  1,4  \nTo cite: Zhou Z, Wang B-Z, Zhang C, et al. Constructing a pancancer ubiquitination regulatory network to determine tumor characteristics, immunotherapy response, and prognosis. Journal for ImmunoTherapy of Cancer 2025;13:e012539 . doi:10 . 1136/ jitc-2025-012539  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[jitc-2025-012539](jitc-2025-012539)) .  \nZZ and B-ZW contributed equally.  \nAccepted 31 July 2025  \n© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nProfessor Jie He; [prof.jiehe@gmail.com](prof.jiehe@gmail.com)  \nProfessor Nan Sun; [sunnan@cicams.ac.cn](sunnan@cicams.ac.cn)  \nABSTRACT  \nBackground Ubiquitination—a pivotal posttranslational modification that orchestrates cellular homeostasis and oncogenic pathways—remains underexplored as a pancancer regulatory hub. Although ubiquitination dysregulation is linked to tumor progression, a comprehensive, multicancer framework integrating prognostic, molecular, and microenvironmental landscapes is lacking.  \nMethods This study integrated data of 4,709 patients from 26 cohorts across five solid tumor types (lung cancer, esophageal cancer, cervical cancer, urothelial cancer, and melanoma) and mapped the molecular profiles to the interaction network. Cox regression and the Kaplan-Meier survival method were employed for prognostic analysis. Functional enrichment and protein–protein interaction analyses were performed to identify the key downstream pathways and genes. Findings were validated using independent patient cohorts, cell line models, and in vivo experiments.  \nResults Key nodes and prognostic pathways  \nwithin the ubiquitination-modification network  \nwere identified. A conserved ubiquitination-related prognostic signature (URPS) effectively stratified patients into high-risk and low-risk groups with distinct survival outcomes across all analyzed cancers. URPS may serve as a novel biomarker for predicting immunotherapy response, with the potential to identify patients who are more likely to benefit from immunotherapy in clinical settings. A comprehensive analysis of URPS-associated proteins revealed novel cancer-related interaction partners as potential drug targets. At the single-cell resolution, URPS enabled more precise classification of distinct cell types and was associated with macrophage infiltration within the tumor microenvironment. In vivo, in vitro, and patient cohort analyses, demonstrated that OTUB1-TRIM28 ubiquitination plays a crucial role in modulating MYC pathway and influencing patient prognosis.  \nConclusion We constructed a pancancer ubiquitination regulatory network and prognostic model, revealing important pathways, and offering insights into predicting patient prognosis and understanding biological mechanisms.  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Ubiquitination is a critical, reversible, and enzymatically regulated process essential for diverse cellular functions including proteolysis, metabolism, signaling, and cell cycle regulation. It plays a complex and crucial regulatory role in cancer development, progression, metabolic reprogramming, and impacts immunotherapy efficacy.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ This study demonstrates that the OTUB1-TRIM28 ubiquitination regulatory enzyme influences the histological fate of cancer cells by modulating MYCand its downstream, and altering oxidative stress, ultimately leading to immunotherapy resistance and poor prognosi","cbCaiiX3cEFsK7jO","https://ap.wps.com/l/cbCaiiX3cEFsK7jO","pdf",7777921,14,"English","# Abstract\n# What is already known on this topic\n# What this study adds\n# How this study might affect research, practice or policy\n# Background","[{\"question\":\"What is the main goal of constructing the pancancer ubiquitination regulatory network?\",\"answer\":\"To build a pancancer ubiquitination regulatory network and prognostic model that reveals important pathways and helps predict patient prognosis and biological mechanisms, including immunotherapy response.\"},{\"question\":\"How were prognostic effects evaluated in this study?\",\"answer\":\"The study used Cox regression and Kaplan-Meier survival methods, integrating patient molecular profiles mapped to the interaction network.\"},{\"question\":\"What is URPS and how does it impact patient risk stratification?\",\"answer\":\"URPS is a conserved ubiquitination-related prognostic signature that stratifies patients into high-risk and low-risk groups with distinct survival outcomes across analyzed cancers.\"},{\"question\":\"Which biological mechanism does the study highlight as crucial for prognosis?\",\"answer\":\"It highlights OTUB1-TRIM28 ubiquitination as a key regulator that modulates the MYC pathway, influences the tumor microenvironment, and affects patient prognosis.\"}]","Constructing a pancancer ubiquitination regulatory network to determine tumor characteristics, immunotherapy response, and prognosis | PDF",1790192854,35,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2bed7a7b98ec45424b28a56ab4f0421.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df088c6e0175feed2948f52984d8d5de.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29c0bbe219b100ed6b5cb66229b1804e.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65d0286d4576eab4ed803a7124996f84.webp",980,1306]